Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcellx (ACLX) EBT (2023 - 2025)

Arcellx has reported EBT over the past 3 years, most recently at -$58.1 million for Q4 2025.

  • For Q4 2025, EBT fell 27.42% year-over-year to -$58.1 million; the TTM value through Dec 2025 reached -$228.9 million, down 117.39%, while the annual FY2025 figure was -$228.9 million, 117.39% down from the prior year.
  • EBT for Q4 2025 was -$58.1 million at Arcellx, down from -$55.8 million in the prior quarter.
  • Over five years, EBT peaked at $20.5 million in Q4 2023 and troughed at -$62.3 million in Q1 2025.
  • A 3-year average of -$33.7 million and a median of -$33.2 million in 2023 define the central range for EBT.
  • Biggest five-year swings in EBT: surged 73.36% in 2024 and later crashed 765.1% in 2025.
  • Year by year, EBT stood at $20.5 million in 2023, then tumbled by 322.69% to -$45.6 million in 2024, then decreased by 27.42% to -$58.1 million in 2025.
  • Business Quant data shows EBT for ACLX at -$58.1 million in Q4 2025, -$55.8 million in Q3 2025, and -$52.7 million in Q2 2025.